Alpha Tau Medical Ltd.
DRTS
$2.62
-$0.02-0.76%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -- | -17.70% | 0.57% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 11.03% | 20.03% | |
| Operating Income | -- | -- | -11.03% | -20.03% | |
| Income Before Tax | -- | -- | 13.64% | 26.26% | |
| Income Tax Expenses | -- | -- | -20.00% | 266.67% | |
| Earnings from Continuing Operations | -- | -- | 13.64% | 26.24% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 13.64% | 26.24% | |
| EBIT | -- | -- | -11.03% | -20.03% | |
| EBITDA | -- | -- | -11.21% | -20.42% | |
| EPS Basic | -- | -- | 36.14% | 48.23% | |
| Normalized Basic EPS | -- | -- | -194.89% | -42.04% | |
| EPS Diluted | -- | -- | 36.14% | 48.23% | |
| Normalized Diluted EPS | -- | -- | -194.89% | -42.04% | |
| Average Basic Shares Outstanding | -- | -- | 9.30% | 22.98% | |
| Average Diluted Shares Outstanding | -- | -- | 9.30% | 22.98% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |